JPWO2020220046A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020220046A5
JPWO2020220046A5 JP2021563641A JP2021563641A JPWO2020220046A5 JP WO2020220046 A5 JPWO2020220046 A5 JP WO2020220046A5 JP 2021563641 A JP2021563641 A JP 2021563641A JP 2021563641 A JP2021563641 A JP 2021563641A JP WO2020220046 A5 JPWO2020220046 A5 JP WO2020220046A5
Authority
JP
Japan
Prior art keywords
architecture
vascular
void
red
light absorber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021563641A
Other languages
Japanese (ja)
Other versions
JP2022529540A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/030153 external-priority patent/WO2020220046A1/en
Publication of JP2022529540A publication Critical patent/JP2022529540A/en
Publication of JPWO2020220046A5 publication Critical patent/JPWO2020220046A5/ja
Pending legal-status Critical Current

Links

Claims (27)

光吸収剤(photoabsorber)を含むハイドロゲルマトリックスと;
それぞれ管状かつ分岐状である第一の血管アーキテクチャおよび第二の血管アーキテクチャを有する、該マトリックス中のボイドアーキテクチャと
を含み、
該第一および第二の血管アーキテクチャが互いから流体的に独立している、
デバイス。
a hydrogel matrix comprising a photoabsorber;
a void architecture in the matrix having a first vascular architecture and a second vascular architecture that are tubular and bifurcated, respectively;
the first and second vascular architectures are fluidly independent from each other;
device.
前記デバイスに入射する可視光の少なくとも90%が該デバイスを透過して該デバイスを画像化することを可能にする、請求項1記載のデバイス。 2. The device of Claim 1, wherein at least 90% of visible light incident on said device is transmitted through said device to allow said device to be imaged. 光吸収剤が少なくとも部分的に前記デバイスから洗い落とされている、請求項1記載のデバイス。 3. The device of Claim 1, wherein the light absorber is at least partially washed out of the device. 光吸収剤が、残りのハイドロゲルマトリックスの任意の分解から独立して分解可能である、請求項1記載のデバイス。 2. The device of Claim 1, wherein the light absorber is degradable independently of any degradation of the remaining hydrogel matrix. 光吸収剤が光脱色または煮沸を含む化学的または物理的プロセスによって分解可能である、請求項1記載のデバイス。 3. The device of claim 1, wherein the light absorber is degradable by chemical or physical processes including photobleaching or boiling . ボイドアーキテクチャが多血管ボイドアーキテクチャであり、トーラス結び目を絡ませたトーラスをさらに含む、請求項1記載のデバイス。 3. The device of claim 1, wherein the void architecture is a multi-vessel void architecture, further comprising a torus entwined with torus knots. 第一の血管アーキテクチャおよび第二の血管アーキテクチャの一方または両方が、多面体のテッセレーションに基づくモデルから形成されている、請求項1記載のデバイス。 3. The device of claim 1, wherein one or both of the first vascular architecture and the second vascular architecture are formed from a polyhedral tessellation-based model. 多面体のテッセレーションに基づくモデルが血管または気道を表す、請求項7記載のデバイス。 8. The device of claim 7 , wherein the polyhedral tessellation-based model represents a blood vessel or airway . ボイドアーキテクチャが多血管ボイドアーキテクチャであり、機能弁をさらに含む、請求項1記載のデバイス。 3. The device of claim 1, wherein the void architecture is a multi-vessel void architecture and further comprising a functional valve. 前記弁が二尖弁、三尖弁、単尖弁またはテスラバルブである、請求項9記載のデバイス。 10. The device of claim 9 , wherein said valve is a bicuspid, tricuspid, unicuspid or Tesla valve. ボイドアーキテクチャが多血管ボイドアーキテクチャであり、流体スタティックミキサをさらに含む、請求項1記載のデバイス。 3. The device of Claim 1, wherein the void architecture is a multi-vessel void architecture, and further comprising a fluidic static mixer. 流体スタティックミキサが2~50のフィンエレメントを有する、請求項11記載のデバイス。 12. The device of claim 11 , wherein the fluid static mixer has 2-50 fin elements. 機能弁が多血管ボイドアーキテクチャ中の任意の位置に配置可能である、請求項9または10記載のデバイス。 11. The device of claim 9 or 10 , wherein the functional valve is positionable anywhere in the multi-vessel void architecture. モノリシックである、請求項1記載のデバイス。 3. The device of claim 1, which is monolithic. ハイドロゲルマトリックスが光重合ハイドロゲルマトリックスおよび/または生分解性ハイドロゲルマトリックスである、請求項1記載のデバイス。 2. The device of claim 1, wherein the hydrogel matrix is a photopolymerized hydrogel matrix and/or a biodegradable hydrogel matrix. 付加製造法によって製造される、請求項1記載のデバイス。 11. The device of claim 1, manufactured by additive manufacturing. 第一の血管アーキテクチャと第二の血管アーキテクチャとが絡み合っている、または、第一の血管アーキテクチャが第二の血管アーキテクチャによって覆われている、請求項1記載のデバイス。 3. The device of claim 1, wherein the first vascular architecture and the second vascular architecture are intertwined or the first vascular architecture is covered by the second vascular architecture . ハイドロゲルマトリックスが多孔質である、請求項1記載のデバイス。 2. The device of claim 1, wherein the hydrogel matrix is porous. 埋め込み型である、請求項1記載のデバイス。 3. The device of claim 1, which is implantable. 光吸収剤が親水性である、請求項1記載のデバイス。 3. The device of Claim 1, wherein the light absorber is hydrophilic. 光吸収剤が、食用色素、タートラジン、サンセットイエローFCF(黄色6号)、ブリリアントブルーFCF(FD&C青色1号)、インジゴカルミン(FD&C青色2号)、ファストグリーンFCF(FD&C緑色3号)アントシアニン、アントシアニジン、エリスロシン(FD&C赤色3号)、アルラレッドAC(FD&C赤色40号)、リボフラビン(ビタミンB2、E101、E101a、E106)、アスコルビン酸(ビタミンC)、キノリンイエローWS、カルモイシン(アゾルビン)、ポンソー4R(E124)、パテントブルーV(E131)、グリーンS(E142)、イエロー2G(E107)、オレンジGGN(E111)、レッド2G(E128)、カラメル色素、フェノールレッド、メチルオレンジ、4-ニトロフェノールおよびNADH二ナトリウム塩のうちの1つである、請求項20記載のデバイス。 Light absorbers include food coloring, tartrazine, sunset yellow FCF (yellow No. 6), brilliant blue FCF (FD&C blue No. 1), indigo carmine (FD&C blue No. 2), fast green FCF (FD&C green No. 3) anthocyanins, Anthocyanidins, Erythrosine (FD&C Red No. 3), Allura Red AC (FD&C Red No. 40), Riboflavin (Vitamin B2, E101, E101a, E106), Ascorbic Acid (Vitamin C), Quinoline Yellow WS, Carmoisine (Azorubine), Ponceau 4R ( E124), Patent Blue V (E131), Green S (E142), Yellow 2G (E107), Orange GGN (E111), Red 2G (E128), caramel color, phenol red, methyl orange, 4-nitrophenol and NADH 21. The device of claim 20 , which is one of sodium salts. 光吸収剤が疎水性である、請求項1記載のデバイス。 3. The device of Claim 1, wherein the light absorber is hydrophobic. 光吸収剤が、クルクミン(E100)、ターメリック、アルファカロテン、ベータカロテン、カンタキサンチン(ケトカロテノイド)、コチニール抽出物、パプリカ、サフラン、エルゴカルシフェロール(ビタミンD2)、コレカルシフェロール(ビタミンD3)、シトラスレッド2、アナトー抽出物およびリコペンのうちの1つである、請求項22記載のデバイス。 Light Absorbers Curcumin (E100), Turmeric, Alpha Carotene, Beta Carotene, Canthaxanthin (Keto Carotenoids), Cochineal Extract, Paprika, Saffron, Ergocalciferol (Vitamin D2), Cholecalciferol (Vitamin D3), Citrus 23. The device of claim 22 , which is one of Red 2, annatto extract and lycopene. 互いから、かつ第一および第二の血管アーキテクチャから流体的に独立した3つ以上の血管アーキテクチャを含む、請求項1記載のデバイス。 2. The device of claim 1, comprising three or more vascular architectures fluidly independent from each other and from the first and second vascular architectures. 流体スタティックミキサが光吸収剤、タートラジン、または180°ねじれを有するフィンエレメントを含む、請求項11記載のデバイス。 12. The device of claim 11 , wherein the fluid static mixer comprises a light absorber , tartrazine, or fin elements with a 180[deg.] twist . 流体スタティックミキサが付加製造法によって製造される、請求項11記載のデバイス。 12. The device of claim 11 , wherein the fluidic static mixer is manufactured by additive manufacturing. 細胞沈降を防ぐための増粘剤をさらに含み、該増粘剤が、0.02重量%~2重量%の範囲の濃度を有するキサンタンガムを含む、請求項1記載のデバイス。 2. The device of claim 1, further comprising a thickening agent to prevent cell sedimentation, said thickening agent comprising xanthan gum having a concentration ranging from 0.02% to 2% by weight .
JP2021563641A 2019-04-26 2020-04-27 Multivascular network in biocompatible hydrogel and functional intravascular topology Pending JP2022529540A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962839358P 2019-04-26 2019-04-26
US62/839,358 2019-04-26
PCT/US2020/030153 WO2020220046A1 (en) 2019-04-26 2020-04-27 Multivascular networks and functional intravascular topologies within biocompatible hydrogels

Publications (2)

Publication Number Publication Date
JP2022529540A JP2022529540A (en) 2022-06-22
JPWO2020220046A5 true JPWO2020220046A5 (en) 2023-04-12

Family

ID=72922202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021563641A Pending JP2022529540A (en) 2019-04-26 2020-04-27 Multivascular network in biocompatible hydrogel and functional intravascular topology

Country Status (10)

Country Link
US (1) US20200339925A1 (en)
EP (1) EP3958926A4 (en)
JP (1) JP2022529540A (en)
KR (1) KR20220006076A (en)
CN (1) CN114245751A (en)
AU (1) AU2020261101A1 (en)
CA (1) CA3134950A1 (en)
IL (1) IL287572A (en)
SG (1) SG11202111873PA (en)
WO (1) WO2020220046A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112826635A (en) * 2021-01-26 2021-05-25 华中科技大学同济医学院附属协和医院 Method for manufacturing breast stent for promoting vascularization
CN117651639A (en) * 2021-05-06 2024-03-05 朗格生物技术公共公益股份有限公司 Additive manufacturing of biomedical hydrogel tubes
JP2024516723A (en) * 2021-05-06 2024-04-16 ラング バイオテクノロジー ピービーシー Biomimetic 3D printing and its applications
US11986999B2 (en) 2021-05-06 2024-05-21 Lung Biotechnology Pbc Modified 3D-printed objects and their uses
GB2608193A (en) * 2021-06-25 2022-12-28 Qdot Tech Ltd Co-sintering
US11730861B2 (en) 2021-10-14 2023-08-22 The Methodist Hospital System Hydrogel devices and methods of making and use thereof
DE102021134544A1 (en) * 2021-12-23 2023-06-29 Fresenius Medical Care Deutschland Gmbh Dialysis machine with compact hydraulic unit

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759830A (en) * 1986-11-20 1998-06-02 Massachusetts Institute Of Technology Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
WO2002053193A2 (en) * 2001-01-02 2002-07-11 The Charles Stark Draper Laboratory, Inc. Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
AU2004313245B2 (en) * 2003-12-30 2011-04-14 Durect Corporation Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH
GB0800981D0 (en) * 2008-01-18 2008-02-27 Plaque Attack Ltd Catheter
JP5487122B2 (en) * 2009-02-06 2014-05-07 学校法人慶應義塾 Stent for use in biological tubular organs
US9232805B2 (en) * 2010-06-29 2016-01-12 Biocure, Inc. In-situ forming hydrogel wound dressings containing antimicrobial agents
MX2015006861A (en) * 2012-11-30 2016-03-04 H David Dean Absorbant and reflecting biocompatible dyes for highly accurate medical implants.
EP2949350B1 (en) * 2014-05-29 2022-05-11 Sabanci Üniversitesi Artificial hollow biological tissue network and method for preparation thereof
WO2016154070A1 (en) * 2015-03-20 2016-09-29 William Marsh Rice University Hypothermic 3d bioprinting of living tissues supported by perfusable vasculature

Similar Documents

Publication Publication Date Title
ES2726534T3 (en) Acid-resistant sealing solution for two-piece acid-resistant hard capsules
US20030148099A1 (en) Microcapsules having high carotenoid content
AU2011226324B2 (en) Compositions for colon lavage and methods of making and using same
ES2298231T3 (en) COMPOSITION OF SUSTAINED RELEASE VITAMIN.
JPWO2020220046A5 (en)
CA2606887C (en) Pharmaceutical composition
ES2860773T3 (en) Compositions and methods useful in treating lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction
EP1492511A2 (en) Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
JP2009525991A (en) Pharmaceutical formulation
US20190105278A1 (en) Shellac microcapsule formulations and compositions
EP1492531B1 (en) Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
ES2881379T3 (en) Composition of coating based on food coloring
ITMI20001285A1 (en) PROENERGETIC FOOD SUPPLEMENT BASED ON NADH OCTOCOSANOL AND VITAMIN E
JP2022000042A (en) Composition including hydrophilic coloring food concentrate and obtainable hard capsule
US11197493B2 (en) Stabilized fat soluble nutrient compositions and process for the preparation thereof
CA3123798A1 (en) Composition for removing crustacean ectoparasites from farmed salmonid fish using curcumin or a pharmaceutical acceptable derivate thereof and light
CN102038644B (en) Lutein water-soluble powder and preparation process thereof
JP2016074643A (en) Processed foods containing tagetes extract
CN101554234A (en) Extract of American cranberry and use thereof
CN108882722A (en) Release vitamin and mineral on time in edible oil
JP2022123274A (en) Enteric-coated hard capsule
JP2020050644A (en) Anthocyanin-containing capsules
Cárdenas-Triviño et al. Microencapsulation of oxolinic acid with chitosan beads
RU2806831C2 (en) Titanium-free compositions providing opacity
BR112018068553B1 (en) USE OF DRY RED-ORANGE PARTICLES AND POWDER FOR INSTANT DRINKS